Pituitary Hormone Release Inhibiting Hormones

DBCAT001948Pharmacologic class

Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. Used for PHRIH in general or for which there is no specific heading. A DrugBank category of 12 drugs. 5 of them are approved.

Also known as: Gonadostatin · Pituitary Hormone-Release Inhibiting Hormones
Drugs: AOD9604
AP-102
Dopastatin
Indium In-111 pentetreotide
Lanreotide
Pareptide
Pasireotide
Pentetreotide
Somatostatin
TT-232
Vapreotide
Veldoreotide

What you can answer from here — as of August 24, 2016

12DrugsEach linked to its full drug card

Listed above

13Drug targetsEvery drug–target pair in the class, with bond type

230Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Pituitary Hormone Release Inhibiting Hormones share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account